Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-12-28

Clinical Trial Update: PET Scans in Assessing Response To Treatment in Patients Receiving Hormone Therapy or Trastuzumab for Breast Cancer

View source ↗

Summary

A completed clinical trial evaluating PET scans to assess treatment response in breast cancer patients receiving hormone therapy or trastuzumab.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hormone therapy
  • Trastuzumab (trastuzumab)

Snippet

Sponsor: University of Washington | Conditions: Breast Cancer | Status: COMPLETED